{"id":236234,"date":"2026-09-16T16:54:10","date_gmt":"2026-09-16T14:54:10","guid":{"rendered":"https:\/\/www.rister.ch\/?p=236234"},"modified":"2026-09-16T16:54:10","modified_gmt":"2026-09-16T14:54:10","slug":"pharmaceutical-company-geneva","status":"publish","type":"post","link":"https:\/\/www.rister.ch\/en\/post\/pharmaceutical-company-geneva\/","title":{"rendered":"Setting up a pharmaceutical, medtech or food supplement company in Geneva: the Swissmedic licence, the site and the Swiss representative"},"content":{"rendered":"<div class=\"intro-box\">\n<p>Setting up a pharmaceutical company in Geneva turns on three questions that incorporation alone does not answer: which product, which activity, which site. A medicinal product requires a Swissmedic establishment licence, attached to a responsible person and to an inspected establishment. A medical device requires no licence, but an authorised representative established in Switzerland. A food supplement is sold without authorisation, once the activity has been notified to the cantonal authority.<\/p>\n<p>In Geneva, such a project is as likely to take the form of a trading company, a distribution subsidiary or a representative office as of a production site. For those first three, misunderstandings are expensive. RISTER\u00ae sets out what a Geneva office does and does not allow.<\/p>\n<\/div>\n<div class=\"table-of-contents\">\n<h3>Contents<\/h3>\n<ol>\n<li><a href=\"#classify\">Classify the product before incorporating<\/a><\/li>\n<li><a href=\"#site\">Is a Geneva office enough? The licence follows a site<\/a><\/li>\n<li><a href=\"#activities\">Trading, importing, brokering: what Swissmedic licenses<\/a><\/li>\n<li><a href=\"#responsible-person\">The responsible person and their independence<\/a><\/li>\n<li><a href=\"#costs\">The cost of a Swissmedic licence<\/a><\/li>\n<li><a href=\"#medtech\">Medtech: the Geneva company as representative or importer<\/a><\/li>\n<li><a href=\"#supplements\">Food supplements: notification and self-monitoring<\/a><\/li>\n<li><a href=\"#premises\">Premises, plans and Geneva taxation<\/a><\/li>\n<li><a href=\"#mistakes\">Mistakes seen on these files<\/a><\/li>\n<\/ol>\n<\/div>\n<h2 id=\"classify\">Classify the product before incorporating<\/h2>\n<p>For a pharmaceutical company in Geneva as anywhere in Switzerland, the classification of the product determines the authority, the authorisations and the key person of the project. The Therapeutic Products Act distinguishes the medicinal product, intended to act medically on the organism or presented as such, from the medical device, &#8220;whose principal action is not obtained by a medicinal product&#8221;. The food supplement falls under food law.<\/p>\n<div class=\"rister-table-wrap\">\n<table class=\"rister-table\">\n<caption class=\"rister-caption\">What each classification requires of the company<\/caption>\n<thead>\n<tr>\n<th>Classification<\/th>\n<th>Company authorisation<\/th>\n<th>Key person or formality<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Medicinal product<\/td>\n<td>Swissmedic establishment licence, after inspection<\/td>\n<td>Responsible person<\/td>\n<\/tr>\n<tr>\n<td>Medical device<\/td>\n<td>No official authorisation<\/td>\n<td>Swiss authorised representative, CHRN registration<\/td>\n<\/tr>\n<tr>\n<td>Food supplement<\/td>\n<td>No authorisation<\/td>\n<td>Cantonal notification, responsible person<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Classification does not depend on the product alone, but also on how it is presented. A vitamin capsule sold with a promise to prevent disease is no longer a foodstuff; software supporting diagnosis may fall within medical devices. The corporate purpose is drafted once that question is settled, not before.<\/p>\n<h2 id=\"site\">Is a Geneva office enough? The licence follows a site<\/h2>\n<p>A Geneva address alone is not enough: a Swissmedic establishment licence is granted for an establishment, a site and a person. The Ordinance on Establishment Licences is explicit: the licence names in particular the responsible person, the authorised activities and the site of the establishment, and it is non-transferable to other persons or to other sites (Art. 40 OEL).<\/p>\n<p>The establishment covers all buildings, installations and means involved in manufacturing, testing, importing, exporting, wholesaling, foreign trading or brokering medicinal products, whether on one site or several (Art. 2(k) OEL). The licence is granted only where the file is complete and the applicant meets all the required conditions &#8220;on each site of the establishment&#8221; (Art. 39 OEL), which the authority verifies by inspection.<\/p>\n<p>In practice, a company domiciled with a third party, with nobody on site and no documentation system, does not meet those requirements. A trading or brokerage office, by contrast, can constitute the establishment, provided the activity is genuinely organised there: responsible person, written procedures, records, checks on counterparties. It is a question of substance, not of address.<\/p>\n<h2 id=\"activities\">Trading, importing, brokering: what Swissmedic licenses<\/h2>\n<p>The Act makes a Swissmedic licence mandatory for anyone who, on a professional basis, manufactures medicinal products (Art. 5 TPA), imports or exports them for distribution or dispensing, trades them abroad from Switzerland without their entering the country, acts as a broker or agent from Switzerland (Art. 18 TPA), or wholesales them (Art. 28 TPA).<\/p>\n<h3>International trading from Geneva<\/h3>\n<p>Take a Geneva company that buys medicines in India and resells them in Africa without the goods transiting through Switzerland: it carries on the &#8220;foreign trade&#8221; of Art. 18(1)(c) TPA, and needs a licence even though no carton enters the country. Where goods are held under customs control, the Act is equally clear: storage in a customs warehouse or a bonded warehouse counts as an import (Art. 18(4) TPA).<\/p>\n<h3>The broker and the agent<\/h3>\n<p>A broker or agent connecting suppliers and buyers must demonstrate a quality assurance system, a responsible person and a documentation system (Art. 24 OEL). The duties of care are precise: ensure that the supplier and the recipient are authorised for the operations they carry out and be able to evidence it, verify that the medicines do not come from illegal trade, and pass on quality and safety information, in particular on recalls (Art. 25 OEL). Agents must also keep copies of the documents relating to the conclusion of transactions.<\/p>\n<div class=\"important-box\">\n<h4>Important<\/h4>\n<p>Dispensing medicines to the public is a cantonal matter, not a Swissmedic one: anyone who dispenses medicinal products must hold a cantonal authorisation (Art. 30 TPA). None of the activities described here may begin before the licence is granted, and no processing time is published. If the classification of your activity is arguable, consult Swissmedic or a specialised lawyer before signing with a supplier.<\/p>\n<\/div>\n<h2 id=\"responsible-person\">The responsible person and their independence<\/h2>\n<p>The responsible person exercises direct technical supervision of the establishment and ensures that medicinal products are handled properly. Their profile determines the licence, and their position in the company&#8217;s governance is regulated.<\/p>\n<ul>\n<li>They may not sit on a supervisory body of the establishment and decide independently from management (Art. 5, 17 and 26 OEL). Swissmedic may allow an exception for companies too small to separate functions.<\/li>\n<li>Where the role is part-time, responsibilities and minimum presence are set out in writing.<\/li>\n<li>They must notify Swissmedic without delay of a cessation of activity, even an imminent one.<\/li>\n<\/ul>\n<div class=\"rister-table-wrap\">\n<table class=\"rister-table\">\n<caption class=\"rister-caption\">Qualification required of the responsible person by activity (OEL)<\/caption>\n<thead>\n<tr>\n<th>Activity<\/th>\n<th>Requirement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Manufacture of ready-to-use medicines<\/td>\n<td>Pharmacist&#8217;s degree and required experience (Art. 6)<\/td>\n<\/tr>\n<tr>\n<td>Manufacture of active ingredients<\/td>\n<td>University degree in science and required experience (Art. 6)<\/td>\n<\/tr>\n<tr>\n<td>Import, export, wholesale<\/td>\n<td>Necessary training, technical knowledge and experience (Art. 18(1))<\/td>\n<\/tr>\n<tr>\n<td>Release onto the Swiss market as holder, or manufacture by a third party<\/td>\n<td>Pharmacist&#8217;s degree and manufacturing experience (Art. 18(2) and Art. 12)<\/td>\n<\/tr>\n<tr>\n<td>Brokerage and agency<\/td>\n<td>Necessary training, technical knowledge and experience (Art. 26)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Swissmedic may recognise other qualifications, and may refuse to consider an application where criminal proceedings are pending against the responsible person; an extract from the criminal record may be required (Art. 39 OEL).<\/p>\n<h2 id=\"costs\">The cost of a Swissmedic licence<\/h2>\n<p>Swissmedic fees are public and comparatively low: CHF 1,500 to grant an establishment licence, CHF 600 to amend one. The real burden on a Geneva pharmaceutical company lies in the responsible person, the quality organisation and the months of processing without revenue.<\/p>\n<div class=\"rister-table-wrap\">\n<table class=\"rister-table\">\n<caption class=\"rister-caption\">Swissmedic Fees Ordinance, Annex 1 and Art. 4<\/caption>\n<thead>\n<tr>\n<th>Item<\/th>\n<th>Amount<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Grant<\/td>\n<td>CHF 1,500<\/td>\n<\/tr>\n<tr>\n<td>Amendment<\/td>\n<td>CHF 600<\/td>\n<\/tr>\n<tr>\n<td>Assessment of inspection reports from regional inspectorates<\/td>\n<td>CHF 200<\/td>\n<\/tr>\n<tr>\n<td>Database update<\/td>\n<td>CHF 100<\/td>\n<\/tr>\n<tr>\n<td>Services charged by time spent, since 1 July 2026<\/td>\n<td>CHF 270 per hour<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Incomplete documentation may trigger a surcharge. Once the licence is held, every change of responsible person, activity or site goes through an amendment application, on which Swissmedic decides within 30 days (Art. 41 OEL). For the record, medicines are industrial products under the customs tariff: they have carried no import duty since 1 January 2024, although import VAT remains due.<\/p>\n<div class=\"rister-cta-inline\">\n<p class=\"rister-cta-kicker\">Pharma, medtech or supplements in Geneva<\/p>\n<p class=\"rister-cta-title\">A company built for the inspection, not for the letterhead<\/p>\n<p>Analysis of the applicable regime, drafting of the corporate purpose, incorporation, allocation of roles between management and the responsible person, then accounting, VAT and payroll: RISTER\u00ae prepares a structure that holds up to Swissmedic requirements, in coordination with your regulatory advisers.<\/p>\n<p>    <a class=\"rister-cta-button\" href=\"https:\/\/www.rister.ch\/en\/contact\/\" target=\"_blank\" rel=\"noopener\">Request a meeting<\/a><br \/>\n    <span class=\"rister-cta-note\">RISTER \u2013 Fiduciary in Geneva, reply within one business day.<\/span>\n<\/div>\n<h2 id=\"medtech\">Medtech: the Geneva company as representative or importer<\/h2>\n<p>A medtech company in Geneva needs no establishment licence: Swissmedic states that, unlike medicinal products, medical devices are not subject to any official authorisation. It can, however, take on a regulatory role that foreign manufacturers actively look for: that of Swiss authorised representative.<\/p>\n<p>Where the manufacturer has no registered office in Switzerland, its devices may only be placed on the market if it has appointed a representative established in Switzerland, under a written mandate (Art. 51 MedDO). The representative handles the formalities of placing the device on the market and the related safety questions, and may agree with the manufacturer that the technical documentation will be sent directly to Swissmedic, in which case it must ensure delivery within seven days.<\/p>\n<ul>\n<li><strong>Registration<\/strong>: before the first placing on the market, the manufacturer or its representative and the importer register with Swissmedic, which assigns a CHRN; changes are notified within one week (Art. 55 MedDO).<\/li>\n<li><strong>Importer<\/strong>: verifies the conformity marking and declaration, the identification of the manufacturer and representative, the labelling and the unique device identifier, and states its name and address on the device or its packaging (Art. 53 MedDO).<\/li>\n<li><strong>Labelling<\/strong>: the representative&#8217;s name and address appear next to the symbol; Swissmedic specifies that a post office box, an email address or a telephone number is not sufficient.<\/li>\n<\/ul>\n<p>That last point ties back to the question of the site: a representative must be reachable at a real address and must assume the duty to cooperate with the authority.<\/p>\n<h2 id=\"supplements\">Food supplements: notification and self-monitoring<\/h2>\n<p>Launching a food supplement brand from Geneva requires no product authorisation. The canton puts it plainly: placing food supplements on the Swiss market requires no authorisation and no specific registration with the authorities. Food law still applies.<\/p>\n<ul>\n<li>The company notifies its activity to the competent cantonal enforcement authority, as any operator handling foodstuffs must (Art. 20 FSGO).<\/li>\n<li>It appoints a responsible person with a business address in Switzerland, in charge of self-monitoring at every stage, proportionate to risk and volume (Art. 73 and 74 FSGO).<\/li>\n<li>It respects the maximum quantities of vitamins and minerals and uses only admitted health claims.<\/li>\n<\/ul>\n<p>The red line is set by the federal food safety office: a supplement must have no pharmacological effect, must not be presented as a medicine and must not claim to cure, alleviate or prevent disease. Crossing that line in advertising or on a sales page moves the product into the medicinal regime.<\/p>\n<h2 id=\"premises\">Premises, plans and Geneva taxation<\/h2>\n<p>As soon as a Geneva pharmaceutical project involves production, two files run in parallel: the Swissmedic file and the premises file. The Labour Act subjects to plan approval not only industrial undertakings but also, among others, chemical and technical production plants and businesses using microorganisms of groups 3 or 4 (Art. 1(2) Ordinance 4 to the Labour Act).<\/p>\n<p>In Geneva, plan review is handled by the cantonal labour inspectorate, the OCIRT. For industrial undertakings it issues a fit-out decision, with the opinion of Suva, then grants the operating licence after an entry-into-service visit. Appointments to file are mandatory for those cases, and the OCIRT states that they are in principle granted within two weeks.<\/p>\n<p>On tax, Geneva is not the patent box canton: relief on profit from patents is 10% there, against 90% in Zurich, Zug, Lucerne or Basel-Stadt and 60% in the canton of Vaud. The additional deduction for research and development expenditure, on the other hand, reaches 50% in Geneva. We set out these parameters in our article on <a href=\"https:\/\/www.rister.ch\/en\/post\/saas-startup-geneva\/\">setting up a SaaS startup in Geneva<\/a>.<\/p>\n<div class=\"conseil-rister\">\n<h4>RISTER advice<\/h4>\n<p>Separate at incorporation what belongs to management and what belongs to the responsible person: organisation chart, job descriptions for key positions, written minimum presence. The ordinance requires these documents for manufacturing (Art. 3(2) OEL) as for import, export and wholesale (Art. 11(1)(c) OEL). A company whose sole director would also be the responsible person must be able to rely on the exception Swissmedic may grant to structures too small to separate the functions.<\/p>\n<\/div>\n<h2 id=\"mistakes\">Mistakes seen on these files<\/h2>\n<p>The most common is to incorporate a pharmaceutical trading company in Geneva, domicile it, and then look for a licence after the first contracts are signed. The order is the reverse: organisation, responsible person, file, inspection, licence, then activity.<\/p>\n<p>Next comes buying a company presented as &#8220;already licensed&#8221;. The licence is non-transferable, attached to a site and a person, and Swissmedic may revoke it after more than twelve months without licensed activity (Art. 42 OEL).<\/p>\n<p>Third: forgetting that storage in a bonded warehouse counts as an import, and organising Geneva warehousing without the corresponding licence.<\/p>\n<p>Fourth, specific to medtech: accepting a Swiss representative mandate without measuring the duties of cooperation, documentation and labelling it carries.<\/p>\n<p>Finally, for food supplements, marketing that promises a therapeutic effect. It is the advertising copy, not the formula, that changes the regime of the product.<\/p>\n<section id=\"faq\">\n<h2>FAQ: setting up a pharmaceutical company in Geneva<\/h2>\n<div class=\"question\">\n<h3>Does a Geneva trading company need a Swissmedic licence if the goods never enter Switzerland?<\/h3>\n<p>Yes. Art. 18(1)(c) TPA requires a licence for anyone trading medicinal products abroad from Switzerland without those products entering the country. Storage in a customs warehouse or a bonded warehouse is in addition treated as an import, which is itself subject to a licence.<\/p>\n<\/p><\/div>\n<div class=\"question\">\n<h3>Can a Swissmedic licence be obtained with a simple domiciliation address?<\/h3>\n<p>An address alone is not enough. The licence names the responsible person, the authorised activities and the site of the establishment, and it is granted only where the conditions are met on each site, which the authority verifies by inspection. A genuinely organised office, with a responsible person and a documentation system, can constitute the establishment of a trading or brokerage activity.<\/p>\n<\/p><\/div>\n<div class=\"question\">\n<h3>What are the fees for a Swissmedic establishment licence?<\/h3>\n<p>The grant costs CHF 1,500 and an amendment CHF 600, plus CHF 200 for the assessment of inspection reports from regional inspectorates and CHF 100 for database updates; services charged by time spent are billed at CHF 270 per hour since 1 July 2026. The responsible person and the quality organisation account for most of the cost.<\/p>\n<\/p><\/div>\n<div class=\"question\">\n<h3>Can a Geneva company act as Swiss authorised representative for medical devices?<\/h3>\n<p>Yes. A manufacturer without a registered office in Switzerland may only place its devices on the Swiss market after appointing, in writing, a representative established in Switzerland (Art. 51 MedDO). The representative registers with Swissmedic, obtains a CHRN and appears with its name and real address on the labelling; medical devices themselves require no establishment licence.<\/p>\n<\/p><\/div>\n<div class=\"question\">\n<h3>Is an authorisation needed to sell food supplements in Geneva?<\/h3>\n<p>No, placing them on the market requires neither authorisation nor product registration. The company does notify its activity to the cantonal enforcement authority, appoints a responsible person with a business address in Switzerland and carries out self-monitoring. The product must not be presented as curing, alleviating or preventing a disease.<\/p>\n<\/p><\/div>\n<div class=\"question\">\n<h3>Is Geneva suitable for a pharmaceutical company holding patents?<\/h3>\n<p>Geneva grants an additional deduction of 50% of research and development expenditure, but only 10% relief on profit from patents, against 90% in Zurich, Zug, Lucerne or Basel-Stadt and 60% in the canton of Vaud. Total relief is capped at 70% of taxable profit. The choice of seat therefore depends on the real activity: trading, research or exploitation of patents.<\/p>\n<\/p><\/div>\n<\/section>\n<section id=\"sources\">\n<h2>Sources<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.fedlex.admin.ch\/eli\/cc\/2001\/422\/fr\" target=\"_blank\" rel=\"noopener\">Federal Act on Medicinal Products and Medical Devices (TPA, SR 812.21), Art. 4, 5, 18, 28 and 30<\/a><\/li>\n<li><a href=\"https:\/\/www.fedlex.admin.ch\/eli\/cc\/2018\/786\/fr\" target=\"_blank\" rel=\"noopener\">Ordinance on Establishment Licences (OEL, SR 812.212.1), Art. 2, 3, 5, 6, 11, 12, 17, 18, 24 to 26, 39 to 42<\/a><\/li>\n<li><a href=\"https:\/\/www.fedlex.admin.ch\/eli\/cc\/2018\/593\/fr\" target=\"_blank\" rel=\"noopener\">Swissmedic Fees Ordinance (SR 812.214.5)<\/a><\/li>\n<li><a href=\"https:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/humanarzneimittel\/bewilligungen_zertifikate\/betriebsbewilligungen.html\" target=\"_blank\" rel=\"noopener\">Swissmedic, Establishment licences<\/a><\/li>\n<li><a href=\"https:\/\/www.fedlex.admin.ch\/eli\/cc\/2020\/552\/fr\" target=\"_blank\" rel=\"noopener\">Medical Devices Ordinance (MedDO, SR 812.213), Art. 51, 53 and 55<\/a><\/li>\n<li><a href=\"https:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/medical-devices\/market-access\/ch-rep.html\" target=\"_blank\" rel=\"noopener\">Swissmedic, Swiss authorised representative (CH-REP)<\/a><\/li>\n<li><a href=\"https:\/\/www.ge.ch\/fabriquer-importer-vendre-complements-alimentaires\" target=\"_blank\" rel=\"noopener\">Canton of Geneva, Food supplements: information for professionals<\/a><\/li>\n<li><a href=\"https:\/\/www.ge.ch\/amenager-locaux-son-entreprise\/comment-faire-examiner-valider-ses-plans-ocirt\" target=\"_blank\" rel=\"noopener\">Canton of Geneva, Having plans reviewed and approved by the OCIRT<\/a><\/li>\n<\/ul>\n<\/section>\n<div class=\"conclusion-box\">\n<h2>Conclusion<\/h2>\n<p>Setting up a pharmaceutical company in Geneva means answering three questions in order: is the product a medicine, a medical device or a foodstuff; does the activity amount to manufacturing, trading, brokering or placing on the market; and where is the establishment that will be inspected. International trading and bonded storage, both common in Geneva, are subject to a licence, and that licence stays tied to a site and to a responsible person independent from management.<\/p>\n<p><strong>RISTER \u2013 Fiduciary in Geneva<\/strong> incorporates your company with a corporate purpose consistent with the regime chosen, through our <a href=\"https:\/\/www.rister.ch\/en\/service\/incorporating-company-in-switzerland-swiss-corporation-limited-liability-sole-proprietorship-geneva\/\">company incorporation service<\/a>, then handles <a href=\"https:\/\/www.rister.ch\/en\/service\/general-administration-geneva\/\">accounting, payroll and tax administration<\/a>. We do not build front structures, and we say so when a step is missing from the file. To discuss it, <a href=\"https:\/\/www.rister.ch\/en\/contact\/\">contact us<\/a>.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Setting up a pharmaceutical company in Geneva turns on three questions that incorporation alone does not answer: which product, which activity, which site. A medicinal product requires a Swissmedic establishment licence, attached to a responsible person and to an inspected establishment. A medical device requires no licence, but an authorised representative established in Switzerland. A [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":236269,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-236234","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"rank_math":{"rank_math_title":"Pharma or Medtech Company in Geneva: Swissmedic Licence and CH-REP","rank_math_description":"Set up a pharma or medtech company in Geneva: Swissmedic licence tied to a site, responsible person, bonded warehouse trade and CH-REP explained.","rank_math_focus_keyword":"pharmaceutical company geneva"},"acf":[],"_links":{"self":[{"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/posts\/236234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/comments?post=236234"}],"version-history":[{"count":2,"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/posts\/236234\/revisions"}],"predecessor-version":[{"id":236244,"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/posts\/236234\/revisions\/236244"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/media\/236269"}],"wp:attachment":[{"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/media?parent=236234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/categories?post=236234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rister.ch\/en\/wp-json\/wp\/v2\/tags?post=236234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}